Women are more likely than men to experience mobility limitations that could benefit from the use of mobility aids but are ...

A team of researchers at The Keck School of Medicine of USC have received a $3.4 million federal grant to advance research on ...

Raw milk, hailed by some as a natural and nutritious alternative to pasteurized dairy, may come with hidden dangers, ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may ...

The World Health Organization (WHO) publishes its first-ever report on drowning prevention, which reveals a 38% drop in the global drowning death rate since 2000-;a major global health achievement.

Australian-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has revolutionised treatment for patients, whereby the body's own immune system is ...

Immune checkpoint blockades, or ICBs, have revolutionized treatment for various advanced cancers. However, their effectiveness has plateaued due to therapeutic resistance that renders ...

During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no difference in mortality rates among patients with advanced cancer compared ...

Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers.

Announcing a new article publication for Zoonoses journal. This study investigates the viral diversity associated with marine organisms in the South China Sea, to improve understanding of the region's ...

More than six million Americans are affected by Alzheimer's disease, a form of dementia marked by accumulation of amyloid-β within the brain. Amyloid-β is a relatively small protein that forms toxic ...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating tumor DNA (ctDNA), failed to accrue enough patients ...